Dec. 10, 2018

Episode 68: MS & AI with Dr. Chase Spurlock, CEO of iQuity

Show Notes

Artificial intelligence is about to change the entire healthcare landscape. And that might very well include how MS is diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. My guest is the founder and CEO of iQuity, Dr. Chase Spurlock. iQuity is using its expertise in machine learning to improve patient care, drive the creation of new therapies, and reduce the costs associated with managing chronic illness, including multiple sclerosis.

We're also talking about the important but sometimes overlooked difference between MS facts and MS beliefs. We'll tell you about the safety alert that the FDA has issued for Lemtrada, and new survey research from the MS Society in the UK that shows the majority of people living with MS are living with feelings of loneliness and isolation.

You'll hear about new study data that shows the gender differences in MS have some age-related fine points that are worth noting, and we'll tell you about a Phase 3 clinical trial that's looking at the effectiveness of high-dose biotin in slowing or stopping MS progression for people living with progressive MS.

We have a lot to talk about! Are you ready for RealTalk MS?!

___________

The Difference Between MS Facts & MS Beliefs 0:22

How AI is About to Disrupt Healthcare 4:21

FDA Issues a Safety Alert for Lemtrada 7:40

MS Society in the UK Survey Research Shows 3 in 5 People Living with MS are Living with Loneliness 9:51

Gender Differences in MS Vary with Age & MS Subtype 13:40

MedDay Phase 3 Clinical Trial for Progressive MS Fully Enrolled 15:55

My Interview with iQuity CEO, Dr. Chase Spurlock 17:50

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes
in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

FDA Warns About Rare But Serious Risks of Stroke & Blood Vessel Wall Tears with Multiple Sclerosis Drug Lemtrada

Age-Dependent Variation of Female Preponderance Across Different Phenotypes of Multiple Sclerosis: A Retrospective Cross-Sectional Study

iQuity

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 68
Hosted By: Jon Strum
Guest: Dr. Chase Spurlock

Tags: MS, MultipleSclerosis, MS, RealTalkMS, mssocietyUK, AI, Lemtrada, MedDay, Biotin, iQuity